4.925

1.10% -0.055

Nutriband Inc (NTRB)

Overview News Price History Financials Discussions Forecast Stock Split

Nutriband Inc stock is traded at $4.925, with a volume of 5,198. It is down -1.10% in the last 24 hours and down -22.20% over the past month. Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Previous Close:

$4.98

Open:

$4.91

24h Volume:

5,198

Relative Volume:

0.17

Market Cap:

$54.59M

Revenue:

$2.09M

Net Income/Loss:

$-5.28M

P/E Ratio:

-8.3475

EPS:

-0.59

Net Cash Flow:

$-3.64M

1W Performance:

+0.72%

1M Performance:

-22.20%

6M Performance:

-0.20%

1Y Performance:

+119.87%

1-Day Range:

$4.71

$5.14

1-Week Range:

$4.64

$5.14

52-Week Range:

$2.22

$9.595

Nutriband Inc Stock (NTRB) Company Profile

Name

Nutriband Inc

Sector

Healthcare (1195)

Industry

Biotechnology (683)

Phone

407 377-6695

Address

121 S. ORANGE AVE., ORLANDO

Employee

Twitter

Next Earnings Date

2024-09-06

Latest SEC Filings

NTRB's Discussions on Twitter

Compare NTRB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NTRB	4.82	54.59M	2.09M	-5.28M	-3.64M	-0.59
VRTX	447.61	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	744.50	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	592.97	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	248.79	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	103.87	24.49B	3.30B	-501.07M	1.03B	11.54

Nutriband Inc Stock (NTRB) Latest News

Nov 08, 2024

(NTRB) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 08, 2024

Nov 02, 2024

Nutriband (NASDAQ:NTRB) Receives Full Patent Approval for AVERSA™ Abuse and Misuse Deterrent Transdermal SystemORLANDO, FL / ACCESSWIRE / October 31, 2024 / Nutriband (NASDAQ:NTRB) has recently disclosed that the Chinese National Intel - Defense World

Nov 02, 2024

Oct 31, 2024

Nutriband Secures Chinese Patent for AVERSA™ Technology - TipRanks

Oct 31, 2024

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application - AccessWire

Oct 31, 2024

Oct 28, 2024

(NTRB) Technical Data - Stock Traders Daily

Oct 28, 2024

Oct 23, 2024

Nutriband (NASDAQ:NTRB) Stock Price Down 8.1%Time to Sell? - MarketBeat

Oct 23, 2024

Nutriband (NASDAQ:NTRB) Stock Price Down 8.1% – Here’s What Happened - Defense World

Oct 23, 2024

Oct 17, 2024

(NTRB) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Oct 17, 2024

Nutriband receives Costa Rica MoH approval for Mosquito Repellent Patch - TipRanks

Oct 17, 2024

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica - AccessWire

Oct 17, 2024

Oct 07, 2024

Objective long/short (NTRB) Report - Stock Traders Daily

Oct 07, 2024

Oct 02, 2024

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17 - AccessWire

Oct 02, 2024

Oct 01, 2024

Analyzing Sanara MedTech (NASDAQ:SMTI) and Nutriband (NASDAQ:NTRB) - Defense World

Oct 01, 2024

BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Receipt of Notice of Allowance for China Patent Application Covering AVERSA(TM) Technology - MSN

Sep 26, 2024

Sep 25, 2024

Head to Head Review: Nutriband (NASDAQ:NTRB) and Jin Medical International (NASDAQ:ZJYL) - Defense World

Sep 25, 2024

Sep 24, 2024

Nutriband secures patent in China for abuse-deterrent patch - Investing.com

Sep 24, 2024

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology - AccessWire

Sep 24, 2024

Sep 23, 2024